Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2016

Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Ophthalmic Imaging Equipment Overview 10
3 Products under Development 11
3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 11
3.2 Ophthalmic Imaging Equipment - Pipeline Products by Segment 12
3.3 Ophthalmic Imaging Equipment - Pipeline Products by Territory 13
3.4 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 14
3.5 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 15
3.6 Ophthalmic Imaging Equipment - Ongoing Clinical Trials 16
4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies 17
4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 17
4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 19
5 Ophthalmic Imaging Equipment Companies and Product Overview 21
5.1 Aeon Imaging, LLC Company Overview 21
5.1.1 Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Aeon Scientific AG Company Overview 22
5.2.1 Aeon Scientific AG Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 ArcScan, Inc. Company Overview 23
5.3.1 ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Ben-Gurion University of the Negev Company Overview 26
5.4.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Brien Holden Vision Institute Company Overview 27
5.5.1 Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 CW Optics, Inc. Company Overview 28
5.6.1 CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Dalhousie University Company Overview 29
5.7.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Exploit Technologies Pte Ltd Company Overview 30
5.8.1 Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 Eye Marker Systems, Inc. Company Overview 31
5.9.1 Eye Marker Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Eye Tech Care SA Company Overview 32
5.10.1 Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Gemss Co.,Ltd. Company Overview 35
5.11.1 Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
5.12 George Washington University Company Overview 36
5.12.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 36
5.13 Massachusetts Eye and Ear Infirmary Company Overview 37
5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 37
5.14 Moorfields Eye Hospital NHS Foundation Trust Company Overview 38
5.14.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 Next Dimension Ltd. Company Overview 41
5.15.1 Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 OcuSciences, Inc. Company Overview 42
5.16.1 OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 Ocutronics, LLC Company Overview 43
5.17.1 Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.18 Ohio State University Company Overview 44
5.18.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 44
5.19 Optos Plc Company Overview 45
5.19.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 45
5.20 PCAsso Diagnostics LLC Company Overview 50
5.20.1 PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 50
5.21 Praevium Research Inc. Company Overview 51
5.21.1 Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.22 Predictek, Inc. Company Overview 52
5.22.1 Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.23 Rensselaer Polytechnic Institute Company Overview 53
5.23.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 53
5.24 RetiVue, LLC Company Overview 54
5.24.1 RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
5.25 Ti-TaMed (PTY) LTD. Company Overview 55
5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 55
5.26 Tufts University Company Overview 56
5.26.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 56
5.27 Universite de Montreal Company Overview 57
5.27.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 57
5.28 University College London Company Overview 59
5.28.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 59
5.29 University of Arizona Company Overview 61
5.29.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 61
5.30 University of California, Los Angeles Company Overview 62
5.30.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 62
5.31 University of Colorado Company Overview 64
5.31.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 64
5.32 University of South Florida Company Overview 65
5.32.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 65
5.33 University of Valencia Company Overview 66
5.33.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 66
5.34 Vision Instruments Pty. Ltd. Company Overview 67
5.34.1 Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.35 VisionQuest Biomedical, LLC Company Overview 68
5.35.1 VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.36 Visual Pathways, Inc. (Inactive) Company Overview 73
5.36.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73
6 Ophthalmic Imaging Equipment- Recent Developments 76
6.1 Nov 07, 2016: Molecular Partners Announces Management Change 76
6.2 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 76
6.3 Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016 77
6.4 Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report 79
6.5 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 80
6.6 Oct 11, 2016: DigiSight Technologies Showcases State-of-the-Art Paxos Scope Mobile Imaging Solution At AAO 2016 81
6.7 Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York 81
6.8 Sep 12, 2016: Canon U.S.A. to Display Eyecare Devices and Solutions at Vision Expo West 82
6.9 Sep 09, 2016: KKR Invests USD66 Million in AcuFocus 83
6.10 Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners 83
6.11 Aug 18, 2016: ContextVision presents Q2 2016 financial report 85
6.12 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 86
6.13 Aug 08, 2016: TearScience Names Edward J. Holland, MD to Board of Directors 87
6.14 Aug 02, 2016: MCW Researchers Lead Imaging Study of Patients with Genetic Color Vision Disorder in Advance of AGTC Gene Therapy Clinical Trials 88
6.15 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results 88
6.16 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 89
6.17 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 90
6.18 Jul 13, 2016: CoxHealth brings diabetic digital retinal imaging to its patients 90
6.19 Jul 06, 2016: Natus Medical Acquires RetCam Ophthalmic Imaging Systems from Clarity Medical Systems for USD10.6 Million 90
6.20 Jul 06, 2016: NOVADAQ Announces Appointment of Rick Mangat as President and CEO 90
6.21 Jun 24, 2016: AcuFocus Raises USD1.9 Million in Venture Financing 91
6.22 May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results 91
6.23 May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 92
6.24 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results 93
6.25 May 05, 2016: TearScience Introduces LipiScan For Rapid High Definition Meibomian Imaging 94
6.26 May 02, 2016: Large UK National Health Services (NHS) Study Finds EyeArt Device To Be the Most Sensitive Automated Retinal Image Analysis Technology for Diabetic Retinopathy Screening 94
6.27 Apr 29, 2016: Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA 95
6.28 Apr 28, 2016: Quarterly Management Statement For The Period Ending March 31, 2016 96
6.29 Apr 14, 2016: ArcScan receives CE Mark Approval for Its Insight 100 device enabling commercialization across Europe 98
6.30 Apr 13, 2016: Molecular Partners Raises USD31.7 Million in Private Placement of Shares 98
6.31 Apr 12, 2016: iSTAR Medical Raises USD11.4 Million in Series B Financing 99
6.32 Mar 22, 2016: Breakthrough Handheld Technology from Welch Allyn Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings 99
6.33 Mar 17, 2016: AcuFocus Raises USD4 Million in Financing 99
6.34 Feb 29, 2016: Canon U.S.A. Showcases Solutions and Services that can Help Healthcare Providers Achieve a More Complete EHR Strategy at HIMSS 2016 100
6.35 Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results 101
6.36 Feb 04, 2016: Molecular Partners reports unaudited financial results for 2015 101
6.37 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 104
6.38 Jan 24, 2016: Fallas Family Vision of McDonough, Georgia, Adds OptoMap Retinal System for an Ultra-Wide View of the Retina During Eye Exams 105
6.39 Jan 15, 2016: Remidio Innovative Solutions Raises Funds in Series B Financing 106
6.40 Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source 106
6.41 Dec 10, 2015: Molecular Partners received a European Small and Mid-Cap Award 106
6.42 Dec 03, 2015: ArcScan Finalizes US Food and Drug Administration Submission for Its Insight 100 Ophthalmic Medical Device 107
7 Appendix 108
7.1 Methodology 108
7.2 About GlobalData 111
7.3 Contact Us 111
7.4 Disclaimer 111

List Of Tables
1.1 List of Tables
Table 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 11
Table 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment 12
Table 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory 13
Table 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 14
Table 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 15
Table 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials 16
Table 7: Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 17
Table 8: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 19
Table 9: Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 10: DLP - Cam - Product Status 21
Table 11: DLP - Cam - Product Description 21
Table 12: Aeon Scientific AG Pipeline Products & Ongoing Clinical Trials Overview 22
Table 13: OctoMag System - Product Status 22
Table 14: OctoMag System - Product Description 22
Table 15: ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 16: Artemis 3 - Product Status 23
Table 17: Artemis 3 - Product Description 23
Table 18: ArcScan, Inc. - Ongoing Clinical Trials Overview 24
Table 19: Artemis 3 - Early Detection of Keratoconus 25
Table 20: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 26
Table 21: Diagnostic Tool - Retinal Disorders - Product Status 26
Table 22: Diagnostic Tool - Retinal Disorders - Product Description 26
Table 23: Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 27
Table 24: Advanced Retinal Imaging System - Product Status 27
Table 25: Advanced Retinal Imaging System - Product Description 27
Table 26: CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 27: RetinalImager - Product Status 28
Table 28: RetinalImager - Product Description 28
Table 29: Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 29
Table 30: Eye Imaging Device - Product Status 29
Table 31: Eye Imaging Device - Product Description 29
Table 32: Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
Table 33: Ocular Surface Disease Diagnostic System - Product Status 30
Table 34: Ocular Surface Disease Diagnostic System - Product Description 30
Table 35: Eye Marker Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 36: RTD 1000 - Product Status 31
Table 37: RTD 1000 - Product Description 31
Table 38: Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview 32
Table 39: EyeOP1 - Product Status 32
Table 40: EyeOP1 - Product Description 32
Table 41: Eye Tech Care SA - Ongoing Clinical Trials Overview 33
Table 42: EyeOP1 - EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma 34
Table 43: EyeOP1 - EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma 34
Table 44: EyeOP1 - Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients 34
Table 45: Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 46: Motorized C-arm System - Product Status 35
Table 47: Motorized C-arm System - Product Description 35
Table 48: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 49: iEye - Product Status 36
Table 50: iEye - Product Description 36
Table 51: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 37
Table 52: Portable Mydriatic Cameras - Product Status 37
Table 53: Portable Mydriatic Cameras - Product Description 37
Table 54: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 38
Table 55: Binocular Optical Coherence Tomography - Product Status 38
Table 56: Binocular Optical Coherence Tomography - Product Description 38
Table 57: Moorfields Eye Hospital NHS Foundation Trust - Ongoing Clinical Trials Overview 39
Table 58: Binocular Optical Coherence Tomography - A Prospective Single-Site Non-Interventional Study to Evaluate Human Factors and Usability of Automated, Comprehensive Ocular Examination in Elderly and Visually Impaired Populations Using a Prototype Binocular Optical Coherence Tomography System 40
Table 59: Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 60: Retinal Spectral Imaging System - Product Status 41
Table 61: Retinal Spectral Imaging System - Product Description 41
Table 62: OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 63: OcuMet Beacon - Product Status 42
Table 64: OcuMet Beacon - Product Description 42
Table 65: Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
Table 66: Ocutronics OC-100 Retinal Camera - Product Status 43
Table 67: Ocutronics OC-100 Retinal Camera - Product Description 43
Table 68: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 44
Table 69: Interferometric Imaging System - Product Status 44
Table 70: Interferometric Imaging System - Product Description 44
Table 71: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 72: 200TX Replacement Device - Product Status 45
Table 73: 200TX Replacement Device - Product Description 46
Table 74: CHARLOTTE - Product Status 46
Table 75: CHARLOTTE - Product Description 46
Table 76: INDIANAPOLIS - Product Status 47
Table 77: INDIANAPOLIS - Product Description 47
Table 78: Optos Plc - Ongoing Clinical Trials Overview 48
Table 79: 200TX Replacement Device - A Randomized Trial of Non-mydriatic Ultra-widefield Retinal Imaging to Screen for Diabetic Eye Disease: CLEAR SIGHT 49
Table 80: PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 50
Table 81: PolyChromatic Angiography Device - Product Status 50
Table 82: PolyChromatic Angiography Device - Product Description 50
Table 83: Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 84: VCSEL Based OCT System - Product Status 51
Table 85: VCSEL Based OCT System - Product Description 51
Table 86: Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 87: IRis - Product Status 52
Table 88: IRis - Product Description 52
Table 89: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 53
Table 90: Video Scheimpflug Camera - Product Status 53
Table 91: Video Scheimpflug Camera - Product Description 53
Table 92: RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
Table 93: CAVCAM - Product Status 54
Table 94: CAVCAM - Product Description 54
Table 95: Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 96: Optical Device - Product Status 55
Table 97: Optical Device - Product Description 55
Table 98: Tufts University Pipeline Products & Ongoing Clinical Trials Overview 56
Table 99: Digital Single Lens Reflex Adaptor - Product Status 56
Table 100: Digital Single Lens Reflex Adaptor - Product Description 56
Table 101: Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 57
Table 102: Diagnostic Software - Ocular Rigidity - Product Status 57
Table 103: Diagnostic Software - Ocular Rigidity - Product Description 58
Table 104: University College London Pipeline Products & Ongoing Clinical Trials Overview 59
Table 105: Ocular Imaging System - Product Status 59
Table 106: Ocular Imaging System - Product Description 60
Table 107: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 61
Table 108: Retinal Illumination System - Product Status 61
Table 109: Retinal Illumination System - Product Description 61
Table 110: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 62
Table 111: Corneal Hydration Sensing System - Product Status 62
Table 112: Corneal Hydration Sensing System - Product Description 63
Table 113: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 64
Table 114: Multi-Photon Optics Device - Product Status 64
Table 115: Multi-Photon Optics Device - Product Description 64
Table 116: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 65
Table 117: Adaptive Optics Ophthalmic Imager - Product Status 65
Table 118: Adaptive Optics Ophthalmic Imager - Product Description 65
Table 119: University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 66
Table 120: 3D Imaging Retinal Camera - Product Status 66
Table 121: 3D Imaging Retinal Camera - Product Description 66
Table 122: Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 123: ViNM1 Retinal Camera - Product Status 67
Table 124: ViNM1 Retinal Camera - Product Description 67
Table 125: VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
Table 126: DR-RACS - Product Status 68
Table 127: DR-RACS - Product Description 69
Table 128: Functional Scanning Laser Ophthalmoscope - Product Status 69
Table 129: Functional Scanning Laser Ophthalmoscope - Product Description 70
Table 130: VisionQuest Biomedical, LLC - Ongoing Clinical Trials Overview 71
Table 131: DR-RACS - Phase 0 Observational Study of a Computer-based Screening Algorithm for Detection of Diabetic Retinopathy 72
Table 132: Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73
Table 133: Aris HySpect - Product Status 73
Table 134: Aris HySpect - Product Description 73
Table 135: Aris Pixie - Product Status 74
Table 136: Aris Pixie - Product Description 74
Table 137: ArisWareEP-3D - Product Status 74
Table 138: ArisWareEP-3D - Product Description 75
Table 139: Glossary 109

List Of Figures
1.2 List of Figures
Figure 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 11
Figure 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment 12
Figure 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory 13
Figure 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 14
Figure 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 15
Figure 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials 16

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.